| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | 1 | — | 2 | 1 | — | 1 | — | — | — | — | 2 | — |
| total | individual payouts | |
|---|---|---|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 36.81 | 57.14 | 49.44 | 131.98 |
| Receivables | 526.87 | 573.79 | 479.25 | 554.11 |
| Inventory | 637.38 | 707.98 | 959.02 | 808.02 |
| Other | — | — | — | — |
| 1,233.71 | 1,369.76 | 1,521.53 | 1,553.26 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 176.66 | 231.81 | 185.13 | 163.56 |
| ST’ Debt | 15.63 | 28.13 | 37.50 | — |
| Other | — | — | — | — |
| 547.15 | 563.80 | 492.83 | 431.76 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 528.77 | 544.60 | — | — |
—
|
| ’25 | 507.69 | 540.96 | 543.74 | 537.93 |
2,130.32
|
| ’24 | 468.70 | 502.95 | 503.77 | 533.77 |
2,009.20
|
| ’23 | 466.74 | 480.57 | 488.19 | 494.30 |
1,929.79
|
| ’22 | 401.58 | 417.42 | 413.47 | 501.28 |
1,733.75
|
| ’21 | 288.01 | 310.64 | 348.43 | 398.18 |
1,345.25
|
| ’20 | 257.73 | 233.18 | 300.62 | 301.22 |
1,092.75
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 43.76 | 152.62 | — | — |
—
|
| ’25 | 51.24 | 8.55 | 12.21 | 41.64 |
113.63
|
| ’24 | 51.98 | 63.35 | 44.29 | 71.43 |
231.05
|
| ’23 | 26.21 | 66.68 | 56.22 | 59.65 |
208.76
|
| ’22 | 23.21 | 14.17 | (8.04) | 12.34 |
41.69
|
| ’21 | 21.02 | 18.07 | 38.51 | 22.74 |
100.34
|
| ’20 | 18.59 | 200.81 | (73.68) | 6.25 |
151.97
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 35.31 | 143.55 | — | — |
—
|
| ’25 | 40.25 | 0.10 | 1.82 | 33.49 |
75.67
|
| ’24 | 41.23 | 51.41 | 35.74 | 63.25 |
191.63
|
| ’23 | 15.67 | 53.94 | 46.56 | 48.62 |
164.79
|
| ’22 | 15.97 | 5.32 | (15.72) | (1.76) |
3.81
|
| ’21 | 14.81 | 14.12 | 33.39 | 18.17 |
80.50
|
| ’20 | 15.09 | 197.17 | (78.60) | 2.86 |
136.52
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.43 | 2.93 | — | — |
—
|
| ’25 | 1.87 | 1.91 | 2.48 | 0.38 |
6.64
|
| ’24 | 1.05 | 1.53 | 1.80 | 1.77 |
6.14
|
| ’23 | 0.18 | 1.04 | 1.28 | 1.60 |
4.10
|
| ’22 | 1.11 | 1.20 | 0.97 | 0.57 |
3.85
|
| ’21 | 1.02 | 0.99 | 1.04 | 1.07 |
4.12
|
| ’20 | 0.70 | 0.43 | 1.06 | 1.11 |
3.30
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 73.32 | 60.01 | 79.20 | 106.95 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 119.04 | 102.25 | 146.60 | 166.89 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,786 | 3,872 | 3,787 | 3,871 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.46 | 0.50 | 0.53 | 0.55 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,733.75 | 1,929.79 | 2,009.20 | 2,130.32 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 32.56% | 35.52% | 40.13% | 42.14% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 156.20 | 168.50 | 256.25 | 275.45 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.01% | 8.73% | 12.75% | 12.93% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 121.55 | 129.26 | 190.00 | 204.19 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 44.68 | 54.73 | 56.70 | 112.44 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 55.16 | 61.35 | 65.24 | 69.75 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 3.85 | 4.10 | 6.14 | 6.64 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.33 | 6.64 | 7.50 | 3.72 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.21) | (1.40) | (1.28) | (1.24) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.12 | 5.24 | 6.22 | 2.48 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.17 | 37.14 | 42.00 | 48.36 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.43 | 31.46 | 30.80 | 30.54 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.51 | 20.34 | 21.07 | 18.55 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.50 | 1.36 | 1.99 | 1.77 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.50 | 2.25 | 3.08 | 2.55 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.76 | 1.59 | 2.19 | 1.95 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 802.26 | 18.62 | 22.96 | 54.88 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 41.69 | 208.76 | 231.05 | 113.63 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (37.88) | (43.97) | (39.42) | (37.97) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.81 | 164.79 | 191.63 | 75.67 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 590.83 | 686.56 | 805.96 | 1,028.70 | — | — | — |
Working Cap'
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 494.96 | 482.86 | 467.64 | 439.91 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 448.93 | 446.05 | 410.50 | 390.48 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,042.63 | 1,168.20 | 1,293.47 | 1,477.08 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.05% | 5.58% | 8.06% | 8.30% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.17% | 8.31% | 10.74% | 10.02% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.31% | 11.69% | 15.44% | 14.74% | — | — | — |
ROE
|
Dorman Products (DORM), a leader in automotive aftermarket parts for aging vehicles, has delivered impressive revenue growth, surging 134% from $860 million in 2016 to over $2 billion in 2024, with an 11% CAGR fueled by post-COVID repair demand, acquisitions like Johanson Transportation, and operational efficiencies boosting revenue per employee to $530K. Profitability has rebounded sharply, with gross margins hitting 40.1%, EPS at $6.14, and free cash flow per share up 19% to $6.22, supporting buybacks and dividends amid solid ROE of 15.4%. Analysts are bullish, forecasting EPS climbing to $10.46 by 2027 and 14-39% stock upside from current levels, with attractive forward P/E ratios of 12.5-15.8x.
Yet, contrarian red flags loom large: persistent insider selling totaling $3.9 million over the past year with zero buys, mounting net debt of $411 million post-acquisitions, and vulnerability to industry headwinds like the EV transition eroding demand for traditional ICE parts, potential tariffs on China-sourced components, and recessionary repair slowdowns. Margins and cash flows remain cyclical, exposed to supply chain scars and rising interest costs, while the stock’s volatility—from 2022 lows to recent mid-range trading—hints at market skepticism despite the growth narrative.
Is DORM a coiled spring of value or a house of cards on temporary tailwinds? Fundamentals scream quality, but consensus optimism may overlook execution risks and an eroding aftermarket moat in a shifting auto landscape—true believers buy dips, skeptics demand proof. Read the full analysis for the deep dive.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.